These data suggest that ISG15 overexpression in ovarian cancer cells may be associated with an increase in the number of CD8+ tumor infiltrating lymphocytes and ISG15 overexpression may also lead to improved patient survival. Here, CD8A is linked to ovarian carcinoma.